Clinical Trial Update: Assessment of Safety, Tolerability and Efficacy of 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% Under Maximum-Use Conditions in Subjects with Primary Axillary Hyperhidrosis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing 1% GPB Cream with Qbrexza glycopyrronium cloth for Primary Axillary Hyperhidrosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axillary Hyperhidrosis

Drugs mentioned

• 1% GPB Cream (glycopyrronium bromide topical cream)
• Qbrexza (Glycopyrronium) Cloth 2.4% (glycopyrronium bromide)

Snippet

Sponsor: Dr. August Wolff GmbH & Co. KG Arzneimittel | Conditions: Primary Axillary Hyperhidrosis | Phase 2 | Status: WITHDRAWN